Flumatinib Plus Venetoclax As an Effective Therapy for Philadelphia Chromosome‐positive Acute Myeloid Leukemia: A Case Report

Philadelphia chromosome-positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long-term remission after the combination of flumatinib and venetoclax, which could provide corresponding treatment ideas for clinical practice.